Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies (Q42925566)
Jump to navigation
Jump to search
scientific article published on 26 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies |
scientific article published on 26 August 2010 |
Statements
1 reference
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies (English)
1 reference
1 reference
D Christoulas
1 reference
M Migkou
1 reference
M Gavriatopoulou
1 reference
M Gkotzamanidou
1 reference
M Iakovaki
1 reference
C Matsouka
1 reference
D Mparmparoussi
1 reference
M Roussou
1 reference
E Efstathiou
1 reference
E Terpos
1 reference
26 August 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference